Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Interest Expenses (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Interest Expenses for 10 consecutive years, with $74051.0 as the latest value for Q4 2022.

  • Quarterly Interest Expenses fell 47.9% to $74051.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $609129.0 through Dec 2022, down 7.77% year-over-year, with the annual reading at $570709.0 for FY2025, 7.76% up from the prior year.
  • Interest Expenses hit $74051.0 in Q4 2022 for Kraig Biocraft Laboratories, down from $74747.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $298444.0 in Q2 2022 to a low of $52371.0 in Q1 2018.
  • Historically, Interest Expenses has averaged $113959.5 across 4 years, with a median of $74051.0 in 2022.
  • Biggest YoY gain for Interest Expenses was 49.51% in 2022; the steepest drop was 60.33% in 2022.
  • Year by year, Interest Expenses stood at $61962.0 in 2018, then increased by 18.26% to $73276.0 in 2019, then soared by 93.96% to $142125.0 in 2021, then tumbled by 47.9% to $74051.0 in 2022.
  • Business Quant data shows Interest Expenses for KBLB at $74051.0 in Q4 2022, $74747.0 in Q3 2022, and $298444.0 in Q2 2022.